pharmaphorum8 年
Brilique boosted by NICE’s long-term prevention recommendation
The draft guidance found that Brilique was cost effective in this setting, costing about £1 per tablet. The decision is great news for AstraZeneca, which is banking on further growth in Brilique ...
pharmaphorum8 年
AZ's key drug Brilique fails in stroke trial
AstraZeneca's Brilinta/Brilique (ticagrelor ... AZ's SOCRATES trial compared Brilinta 90mg tablets twice daily, to aspirin 100mg once daily in patients who had just suffered an acute ischaemic ...